Catalog excerpts
About us AB ANALITICA was one of the first Italian companies to operate in the field of molecular diagnostics and today boasts over 30 years of experience in the design, development, production and marketing of in vitro diagnostics. A long journey, in step with the rapid evolution of this sector, without ever losing sight of the goals we set for our customers: Innovation, qualified Assistance, certified Safety and Quality. SAFETY CERTIFIED QUALITY Design, Development and Innovation We are proud to be one of the few national companies with its own Research and Development division, comprised...
Open the catalog to page 3Quality The quality of our service and our products is ensured by the UNI EN ISO 9001 and UNI CEI EN ISO 13485 certifications for the design, development, production and marketing of in vitro diagnostic medical devices (IVD), instrumentation and software, as well as from the certification of our Quality Management System in accordance with art. 10(8) of Regulation (EU) 2017/746 relating to in vitro diagnostic medical devices. AB ANALITICA for the certification procedures makes use of the Notified Body TÜV SÜD (0123). SI ATTESTA CHE / THIS IS TO CERTIFY THAT Si attesta che / This is to...
Open the catalog to page 4EU Quality Management System Certificate (IVDR) Pursuant lo Regulation (EU) 20 17V746 on in Vitro Diagnostic Medical Devices. Annex IX Chapters I and III (Class C anc B Devices excluding self-riiear-palisnl-lesnng and Companion Diagnostics) NO. V12 058438 0015 Rev. 00 FICATE ♦ igstsSM ♦ CEPTHfHKAT ♦ CERTIFICA SRN Manufacturer: fiat available at issuance date of this certificate Tlie Ccitificatiur Btxly ot TUV SUD Product Stavice GmbH certifies mat me manufacturer Has established, documented and impemented a quality managument system as described in Artioie to (8) of the Regulation (EU)...
Open the catalog to page 5REALQUALITY - Real Time PCR 7 Sexually Transmitted Infections (STIs) Gastrointestinal infections 16 Monitoring Antiviral Tnerapy (ART) 16 “Vector Borne" Infections 17 Reverse Line Blot - Genetics 21 Reverse Line Blot - Virology 23 Automated extraction and PCR setup • GENEQUALITY® X120
Open the catalog to page 6REALQUALITY Real Time PCR
Open the catalog to page 7RealQualityReal Time PCR Real Time PC Attention! Please specify the Real-Time PCR system the client uses with every order. For most kits: Qualitative and quantitative essays. PKG: 50/100 - 48/96 tests. Stability of kits up to 18 months. Most assays require 5 pL of extracted nucleic acid. dUTP/UNG system for contamination prevention. Endogenous internal control (IC) in mutiplex with the pathogen target. Internal control to be included in the extraction step for acellular matrices.
Open the catalog to page 8Transplant monitoring Rejection and infection are the main causes of transplant failure and are two intimately associated and interdependent processes. Immunosuppressive therapies create a favorable condition for the onset of infectious processes and it is therefore extremely important to monitor the patient periodically before and after the transplant to prevent the occurence of rejection.
Open the catalog to page 9Transplant monitoring
Open the catalog to page 10Transplant monitoring * Lyophilized format Meningitis and encephalitis are acute inflammatory diseases affecting the central nervous system. They are often very serious and can be due to various etiological agents of viral, bacterial, fungal or parasitic origin. The rapidity in the diagnosis of meningitis/encephalitis and the patient’s prognosis are closely related and the Real-Time PCR technology enables rapid and efficient diagnosis. Kit for detection of REALQUALITY Cytomegalovirus Quantification standards for Cytomegalovirus Kit for detection of Epstein-Barr virus RQ-EBV Quantification...
Open the catalog to page 11RealQuality Real Time PCR
Open the catalog to page 12REALQUALITY Identification and quantification RQ-ResP-PnJ * (standard included) of Pneumocystis jirovecii Quantification standards for Enterovirus Lyophilized format
Open the catalog to page 13Respiratory infections Application REALQUALITY Identification of the ORFlab, N and S genes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Identification of respiratory viruses SARS-CoV-2, Influenza A and Influenza B REALQUALITY ResP-REM REALQUALITY RQ-InFLU-Typing * REALQUALITY RQ-P-InFLU * REALQUALITY RQ-ResP-AMB * REALQUALITY RQ-ResP-RhinEV * REALQUALITY RQ-Mers-CoV * REALQUALITY RQ-h-CoVs * REALQUALITY RQ-GAS * Identification of respiratory viruses severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Influenza A, Influenza B and respiratory syncytial virus (RSV)...
Open the catalog to page 14AValidated with Lysis Buffer SW for rapid manual extraction of nucleic acids
Open the catalog to page 15Gastrointestinal infections RealQualityReal Time PCR Gastrointestinal infections of viral, bacterial, or parasitic origin cause diseases resulting in inflammation of the gastrointestinal tract (stomach, small intestine, and colon), typically manifested by diarrhea, vomiting, and abdominal pain. Prompt diagnosis is a crucial measure to providethe correct therapy in a timely manner and to control the infection. * Lyophilized format The total amount of HIV DNA in blood or peripheral blood mononuclear cells (PBMCs) provides information on both the pathogenesis and the course of the infection....
Open the catalog to page 16RealQuality Real Time PC Vector-borne infections are diseases resulting from the transmission of an infectious agent from an infected animal to humans or another animal. The vectors are often arthropods such as mosquitoes, ticks, flies, fleas and lice, but also mammals such as mice and cats (e.g. Toxoplasma gondii), and they can transmit infectious diseases either actively or passively. * Lyophilized format Antibiotic resistance Antimicrobial resistance is a growing global health problem (WHO, 2014). The World Health Organization has placed the development of new antibacterial agents to...
Open the catalog to page 17- -RealQuality Real Time PCR Clotting disorders are dysfunctions in the body’s ability to control the formation of blood clots. They occur when the body is unable to produce enough proteins, called clotting factors, needed to start clotting and stop bleeding. In cases where there is a genetic abnormality of these factors, hereditary thrombophilia can arise. Molecular testing represents the gold standard for screening for genetic defects that predispose to hereditary thrombophilia.
Open the catalog to page 18All AB Analitica catalogs and technical brochures
-
EQA PROGRAMME CATALOGUE
77 Pages
-
AB 13C Breath test
4 Pages
-
PRODUCT CATALOG 2018
16 Pages
-
HP UREASI TEST
2 Pages
-
RS-FACTOR V LEIDEN
1 Pages
-
HPV-TYPE EXPRESS
2 Pages
-
PRODUCT LIST 2017
20 Pages
-
GENEQUALITY DDK-G17
1 Pages
-
Product list 2016
24 Pages